Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Times Interest Earned (2022 - 2025)

Atara Biotherapeutics' Times Interest Earned history spans 4 years, with the latest figure at -$35.3 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 194.15% year-over-year to -$35.3; the TTM value through Dec 2025 reached $1.81, up 110.02%, while the annual FY2025 figure was $1.81, 110.02% up from the prior year.
  • Times Interest Earned reached -$35.3 in Q4 2025 per ATRA's latest filing, down from -$3.93 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $38.15 in Q1 2025 to a low of -$22055.0 in Q1 2022.
  • Average Times Interest Earned over 4 years is -$1494.8, with a median of -$42.6 recorded in 2023.
  • The largest YoY upside for Times Interest Earned was 240.78% in 2025 against a maximum downside of 194.15% in 2025.
  • A 4-year view of Times Interest Earned shows it stood at -$645.63 in 2022, then surged by 92.1% to -$50.99 in 2023, then surged by 76.47% to -$12.0 in 2024, then crashed by 194.15% to -$35.3 in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Times Interest Earned are -$35.3 (Q4 2025), -$3.93 (Q3 2025), and $3.29 (Q2 2025).